Lilly's Foundayo Gains Share as Viking and Roche Reveal Strong Obesity Drug Data

SentiSense · Published Sep 21, 2026, 2:57 PM ET · Updated Sep 22, 2026, 12:12 PM ET

Eli Lilly CEO Dave Ricks said one-third of new GLP-1 pill patients are now taking Foundayo, as Lilly broke ground on a $6.5 billion Houston plant. Vik...